Related Experiment Video
Updated: Feb 10, 2026
10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
33.4K
[SPECIFIC FEATURES AND PROSPECTS OF THE PHARMACOKINETIC STUDY OF HISTOCHROME.]
Eksperimental'Naia I Klinicheskaia Farmakologiia
|May 24, 2018
Summary
This review examines the pharmacokinetics of the Russian drug Histochrome, derived from echinochrome A. Further research into its metabolism and dosing is recommended for improved therapeutic use.
Area of Science:
- Pharmacology
- Marine natural products chemistry
Background:
- Histochrome is a novel Russian pharmaceutical agent.
- Its active compound is echinochrome A, a quinoid pigment from marine invertebrates.
Purpose of the Study:
- To review existing pharmacokinetic data for Histochrome.
- To explore the relationship between pharmacokinetics and pharmacodynamics.
- To identify areas for future research on Histochrome's metabolism and therapeutic application.
Main Methods:
- Literature review of available pharmacokinetic data.
- Analysis of echinochrome A structure and properties.
- Discussion of potential metabolic pathways and active metabolites.
Main Results:
- Summary of current knowledge on Histochrome pharmacokinetics.
- Identification of gaps in understanding echinochrome A metabolism.
- Highlighting the need for optimized administration and dosing strategies.
Conclusions:
- Further investigation into Histochrome's pharmacokinetics, metabolism, and dosing is crucial.
- Optimizing these aspects can enhance the drug's therapeutic efficacy.
- Echinochrome A's potential as a therapeutic agent warrants continued study.
Related Concept Videos
01:10Pharmacokinetics: Overview
9.7K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.7K
01:20Pharmacokinetic Models: Overview
2.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.2K
01:19Nonlinear Pharmacokinetics: Overview
1.1K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K
01:22Nonlinear Pharmacokinetics: Causes of Nonlinearity
742
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
742
01:20COPD: Pathogenesis and Clinical Features
1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
01:20Special Features of Adaptive Immunity
3.4K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.4K